Skip to main navigation Skip to search Skip to main content

Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines

  • Nadav Orr*
  • , Eyal Klement
  • , David Gillis
  • , Tamar Sela
  • , Raid Kayouf
  • , Estela Derazne
  • , Itamar Grotto
  • , Ran Balicer
  • , Michael Huerta
  • , Lisa Aviram
  • , Ruhama Ambar
  • , Yoram Epstein
  • , Yuval Heled
  • , Dani Cohen
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

We evaluated in a prospective study the immune response of naïve subjects to a single dose of inactivated Hepatitis A vaccine. Ninety-seven percent of the vaccinees sero-converted 1 month after vaccination and 93% were still positive 2 years later. All of the vaccinees had a strong booster response 2 years after the single dose. Avaxim was more immunogenic than Vaqta for the primary dose (p = 0.01 for sero-positivity, p < 0.001 for antibody level) but no differences were found after boosting with Avaxim. Performance of intense physical activity during the first month after a single vaccine dose was associated with lower antibody levels (p = 0.004). This study indicates that a single dose of inactivated HAV vaccine elicits protective immune memory for at least 2 years.

Original languageEnglish
Pages (from-to)4328-4332
Number of pages5
JournalVaccine
Volume24
Issue number20
DOIs
StatePublished - 15 May 2006
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Hepatitis A vaccine
  • Long term protection
  • Single dose

Fingerprint

Dive into the research topics of 'Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines'. Together they form a unique fingerprint.

Cite this